Nitroxyl (HNO) Stimulates Soluble Guanylyl Cyclase to Suppress Cardiomyocyte Hypertrophy and Superoxide Generation

BACKGROUND: New therapeutic targets for cardiac hypertrophy, an independent risk factor for heart failure and death, are essential. HNO is a novel redox sibling of NO• attracting considerable attention for the treatment of cardiovascular disorders, eliciting cGMP-dependent vasodilatation yet cGMP-in...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Eliane Q., Irvine, Jennifer C., Cao, Anh H., Alexander, Amy E., Love, Jane E., Patel, Ruchi, McMullen, Julie R., Kaye, David M., Kemp-Harper, Barbara K., Ritchie, Rebecca H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323591/
https://www.ncbi.nlm.nih.gov/pubmed/22506056
http://dx.doi.org/10.1371/journal.pone.0034892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323591/
https://www.ncbi.nlm.nih.gov/pubmed/22506056
http://dx.doi.org/10.1371/journal.pone.0034892

Ejemplares similares